Enhancement of antibacterial activity of clofazimine against Mycobacterium avium-Mycobacterium intracellulare complex infection induced by IFN-γ is mediated by TNF-α

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 2, 1997, Pages 189-197

  Gomez Flores, Ricardo ^a   Tucker, Stanley D ^a   Kansal, Rita ^a   Tamez Guerra, Reyes ^b   Mehta, Reeta T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; GAMMA INTERFERON; LIPOSOME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL CULTURE; ENCAPSULATION; FEMALE; MACROPHAGE ACTIVATION; MALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PERITONEUM MACROPHAGE;

ANIMALS; ANTI-BACTERIAL AGENTS; CLOFAZIMINE; FEMALE; INTERFERON TYPE II; LIPOSOMES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; OMEGA-N-METHYLARGININE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031044645     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.2.189     Document Type: Article

References (40)

1. Horsburgh, C. R. (1991). Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. New England Journal of Medicine 324, 1332-8.
2. Iseman, M. D., Corpe, R. F., O'Brien, R. J., Rosenzwieg, D. Y. & Wolinsky, E. (1985). Disease due to Mycobacterium aviumintracellulare. Chest 87, Suppl. 2, 139S-49S.
3. Bermudez, L. E. M. & Young, L. S. (1988). Tumor necrosis factor, alone or in combination with IL-2, but not IFN-γ, is associated with macrophage killing of Mycobacterium avium complex. Journal of Immunology 140, 3006-13.
4. Denis, M. (1991). Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. Journal of Leukocyte Biology 49, 380-7.
5. Denis, M. (1991). Modulation of Mycobacterium avium growth In vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria. Clinical and Experimental Immunology 83, 466-71.
6. Appelberg, R., Castro, A. G., Pedrosa, J., Silva, R. A., Orme, I. M. & Minóprio, P. (1994). Role of gamma Interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infection and Immunity 62, 3962-71.
7. Barry, V. C., Belton, J. G., Conalty, M. L., Denneny, J. M., Edward, D. W., O'Sullivan, J. F. et al. (1957). A new series of phenazines (rimino-compounds) with high antituberculosis activity. Nature 179, 1013-5.
8. Levy, L., Shephard, C. C. & Fasal, P. (1972). Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant Mycobacterium leprae. American Journal of Tropical Medicine and Hygiene 21, 315-21.
9. Agins, B. D., Berman, D. S., Spicehandler, D., el-Sadr, W., Simberkoff, M. S. & Rahal, J. J. (1989). Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. Journal of Infectious Diseases 159, 784-7.
10. Garrelts, J. C. (1991). Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection. DICP-Annals of Pharmacotherapy 25, 525-31.
11. Mayhew, E. G. & Papahadjopoulos, D. (1983). Therapeutic applications of liposomes. In Liposomes (Ostro, M. J., Ed.), pp. 289-341. Marcel Dekker, New York.
12. Ashtekar, D., Düzgünes, N. & Gangadharam, P. R. J. (1991). Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages. Journal of Antimicrobial Chemotherapy 28, 615-7.
13. Kesavalu, L., Goldstein, J. A., Debs, R. J., Düzgünes, N. & Gangadharam, P. R. J. (1990). Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages. Tubercle 71, 215-7.
14. Gangadharam, P. R. J., Ashtekar, D. A., Ghori, N., Goldstein, J. A., Debs, R. J. & Düzgünes, N. (1991). Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. Journal of Antimicrobial Chemotherapy 28, 425-35.
15. Kansal, R. G., Gomez-Flores, R., Sinha, I. & Mehta, R. T. (1997). Therapeutic efficacy of liposomal clofazimine against Mycobacterium avium complex depends on size of inoculum and duration of injection. Antimicrobial Agents and Chemotherapy 41, in press.
16. Mehta, R. T. (1996). Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex (MAC) infection. Antimicrobial Agents and Chemotherapy 40, 1893-902.
17. Mehta, R. T., Keyhani, A., McQueen, T. J., Rosenbaum, B., Rolston, K. V. & Tarrand, J. J. (1993). In vitro activities of free and liposomal drugs against Mycobacterium avium-intracellulare complex and M. tuberculosis. Antimicrobial Agents and Chemotherapy 37, 2584-7.
18. Gomez-Flores, R., Gupta, S., Tamez-Guerra, R. & Mehta, R. T. (1995). Determination of MICs for Mycobacterium avium-M. Intracellulare complex in liquid medium by a colorimetric method. Journal of Clinical Microbiology 33, 1842-6.
19. Gangadharam, P. R. J. & Pratt, P. F. (1983). In vitro response of murine alveolar and peritoneal macrophages to Mycobacterium Intracellulare. American Review of Respiratory Disease 128, 1044-7.
20. Suzuki, K., Lee, W. J., Hashimoto, T., Tanaka, E., Murayama, T., Amitani, R. et al. (1994). Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-α) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex. Clinical and Experimental Immunology 98, 169-73.
21. Douvas, G. S., May, M. H., Ross, E. & Crowle, A. J. (1992). Characterization of inhibition of Mycobacterium avium replication in macrophages by normal human serum. Infection and Immunity 60, 345-52.
22. Tucker, S. D., Sivaramakrishnan, M. R., Klostergaard, J. & Lopez-Berestein, G. (1991). Independence of the pattern of early cytokine release from autoregulation by nitric oxide. Journal of Leukocyte Biology 50, 509-16.
23. Klostergaard, J. (1985). A rapid extremely sensitive, quantitative microassay for cytotoxic cytokines. Lymphokine Research 4, 309-17.
24. Doherty, G. M., Jensen, J. C., Alexander, H. R., Buresh, C. M. & Norton, J. A. (1991). Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110, 192-8.
25. Dezube, B. J., Lederman, M. M., Spritzler, J. G., Chapman, B., Korvick, J. A., Flexner, C., et al. (1995). High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. Journal of Infectious Diseases 171, 628-32.
26. 3H]glycerol radioassay for determination of monocyte-mediated growth inhibition of Mycobacterium avium. Journal of Immunological Methods 133, 285-90.
27. Gangadharam, P. R. J. (1995). Beige mouse model for Mycobacterium avium complex disease. Antimicrobial Agents and Chemotherapy 39, 1647-54.
28. Talmadge, J. E., Tribble, H. R., Pennington, R. W., Phillips, H. & Wiltrout, R. H. (1987). Immunomodulatory and immunotherapeutic properties of recombinant γ-interferon and recombinant tumor necrosis factor in mice. Cancer Research 47, 2563-70.
29. Al-Ramadi, B. K., Meissler, J. J., Huang, D. & Eisenstein, T. K. (1992). Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. European Journal of Immunology 22, 2249-54.
30. Albina, J. E., Mills, C. D., Henry, W. L. & Caldwell, M. D. (1989). Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway. Journal of Immunology 143, 3641-6.
31. Dumarey, C. H., Labrousse, V., Rastogi, N., Vargaftig, B. B. & Bachelet, M. (1994). Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. Journal of Leukocyte Biology 56, 36-40.
32. Appelberg, R. & Orme, I. M. (1993). Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. Immunology 80, 352-9.
33. Bermudez, L. E. M., Stevens, P., Kolonoski, P., Wu, M. & Young, L. S. (1989). Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor. Journal of Immunology 143, 2996-3000.
34. Holland, S. M., Eisenstein, E. M., Kuhns, D. B., Turner, M. L., Fleisher, T. A., Strober, W. et al. (1994), Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. New England Journal of Medicine 330, 1348-55.
35. Bermudez, L. E. M. & Young, L. S. (1988). Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. Antimicrobial Agents and Chemotherapy 32, 1149-53.
36. Bermudez, L. E., Martinelli, J., Petrofsky, M., Kolonoski, P. & Young, L. S. (1994). Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. Journal of Infectious Diseases 169, 575-80.
37. Onyeji, C. O., Nightingale, C. H., Tessier, P. R., Nicolau, D. P. & Bow, L. M. (1995). Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. Journal of Infectious Diseases 172, 810-6.
38. Tracy, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C. et al. (1987). Anti-cachectin/VTNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662-4.
39. Collart, M. A., Belin, D., Vassalli, J. D., de Kossodo, S. & Vassalli, P. (1986). γ-Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressers. Journal of Experimental Medicine 164, 2113-8.
40. Krajewska, M. M., Anderson, R. & O'Sullivan, J. F. (1993). Effects of clofazimine analogues and tumor necrosis factor-α individually and in combination on human polymorphonuclear leukocyte functions in vitro. International Journal of Immunopharmacology 15, 99-111.